Skip to main navigation

About
- About
- Contact Us
Pipeline
Science
- Science
- DKK1
- DKN-01
- Claudin18.2
- GDF15
Patients
- Patients
- Expanded Access
Careers
Investors

Event
Details

image description

ASCO GI 2024 DeFianCe Study Webcast

Jan 23, 2024 at 8:30 AM EST

Click here for webcast

Supporting Materials

ASCO GI 2024 DeFianCe Study Presentation 6.3 MB

Print Page
Email Alerts
Contact Us

image description

image description

47 Thorndike Street, Suite B1-1 Cambridge, MA 02141 USA

+1 617 714 0360

Business inquiries
bd@leaptx.com

Investor inquiries
ir@leaptx.com

ABOUT
CONTACT US

CAREERS

PIPELINE
DKN-01 PROGRAMS
ANTI-CLDN18.2 PROGRAMS
FL-501

PATIENTS
EXPANDED ACCESS

SCIENCE
DKK1
DKN-01
CLAUDIN18.2
GDF15

INVESTORS
STOCK INFORMATION
NEWS RELEASES
PRESENTATIONS & EVENTS
FINANCIAL INFORMATION
CORPORATE GOVERNANCE
INFORMATION REQUEST

© 2023 Leap Therapeutics, Inc.
All Rights Reserved.

Terms of Use
Privacy Policy
Cookie Policy